Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.

2.50
Hdl Handle:
http://hdl.handle.net/10541/95907
Title:
Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.
Authors:
Mackett, Mike; Cox, C; Pepper, Stuart D; Lees, Janice F; Naylor, B A; Wedderburn, N; Arrand, John R
Abstract:
Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with a variety of life-threatening diseases in humans. Therefore the development of an effective vaccine is an important objective. Many of the initial studies of vaccine efficacy analyse the ability of vaccine preparations to prevent the induction of lymphomas in cottontop tamarins by the B95-8 strain of EBV. We used a vaccinia virus recombinant expressing gp340, vMA1, tested previously in the cotton-top tamarin, to evaluate a common marmoset model in which the challenge virus, M81, resembles more closely the wild-type strains of EBV in the general population than does the standard B95-8 strain. We characterised the M81 strain of EBV with respect to the sequence of its gp340/220 gene and in regard to the presence of a region deleted in B95-8. Replication of the challenge virus in the group vaccinated with vMA1 was decreased when compared to control groups.
Affiliation:
Department of Molecular Biology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Withington, Manchester, England.
Citation:
Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV. 1996, 50 (3):263-71 J. Med. Virol.
Journal:
Journal of Medical Virology
Issue Date:
Nov-1996
URI:
http://hdl.handle.net/10541/95907
DOI:
10.1002/(SICI)1096-9071(199611)50:3<263::AID-JMV9>3.0.CO;2-7
PubMed ID:
8923292
Type:
Article
Language:
en
ISSN:
0146-6615
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorMackett, Mikeen
dc.contributor.authorCox, Cen
dc.contributor.authorPepper, Stuart Den
dc.contributor.authorLees, Janice Fen
dc.contributor.authorNaylor, B Aen
dc.contributor.authorWedderburn, Nen
dc.contributor.authorArrand, John Ren
dc.date.accessioned2010-04-07T14:39:57Z-
dc.date.available2010-04-07T14:39:57Z-
dc.date.issued1996-11-
dc.identifier.citationImmunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV. 1996, 50 (3):263-71 J. Med. Virol.en
dc.identifier.issn0146-6615-
dc.identifier.pmid8923292-
dc.identifier.doi10.1002/(SICI)1096-9071(199611)50:3<263::AID-JMV9>3.0.CO;2-7-
dc.identifier.urihttp://hdl.handle.net/10541/95907-
dc.description.abstractEpstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with a variety of life-threatening diseases in humans. Therefore the development of an effective vaccine is an important objective. Many of the initial studies of vaccine efficacy analyse the ability of vaccine preparations to prevent the induction of lymphomas in cottontop tamarins by the B95-8 strain of EBV. We used a vaccinia virus recombinant expressing gp340, vMA1, tested previously in the cotton-top tamarin, to evaluate a common marmoset model in which the challenge virus, M81, resembles more closely the wild-type strains of EBV in the general population than does the standard B95-8 strain. We characterised the M81 strain of EBV with respect to the sequence of its gp340/220 gene and in regard to the presence of a region deleted in B95-8. Replication of the challenge virus in the group vaccinated with vMA1 was decreased when compared to control groups.en
dc.language.isoenen
dc.subject.meshAmino Acid Sequence-
dc.subject.meshAnimals-
dc.subject.meshAntibodies, Viral-
dc.subject.meshCallithrix-
dc.subject.meshCell Line-
dc.subject.meshDNA, Viral-
dc.subject.meshDisease Models, Animal-
dc.subject.meshFemale-
dc.subject.meshFluorescent Antibody Technique, Indirect-
dc.subject.meshGenetic Vectors-
dc.subject.meshHerpesvirus 4, Human-
dc.subject.meshImmunization-
dc.subject.meshInfectious Mononucleosis-
dc.subject.meshMale-
dc.subject.meshMolecular Sequence Data-
dc.subject.meshMouth Mucosa-
dc.subject.meshVaccines, Synthetic-
dc.subject.meshVaccinia virus-
dc.subject.meshViral Matrix Proteins-
dc.subject.meshViral Vaccines-
dc.titleImmunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.en
dc.typeArticleen
dc.contributor.departmentDepartment of Molecular Biology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Withington, Manchester, England.en
dc.identifier.journalJournal of Medical Virologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.